Sequencing Companies Join Genetic Mapping Effort
The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research.
The 1000 Genomes Project announced that three companies involved in the development of new sequencing instrumentation have joined an international effort to build a detailed map of human genetic variation for medical research. The new participants are 454 Life Sciences, a Roche company (Branford, Connecticut); Applied Biosystems, an Applera Corp. business (Foster City, California); and Illumina Inc. (San Diego, California). The 1000 Genomes Project is an international research consortium formed in January 2008 with a goal of creating a new map of the human genome to show biomedically relevant DNA variations at a higher resolution than current techniques.
Examining Alkaloid Profiles in Milk with LC-MS
February 10th 2025Research conducted by The Technology Transfer Center of the Edmund Mach Foundation (San Michele all'Adige, Italy) and the University of Udine (Udine, Italy) used liquid chromatography coupled with high-resolution mass spectrometry (LC-MS) to investigate alkaloid transfer from alpine pastures to milk.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
